Cancer trials in sub-Saharan Africa: Aligning research and care

Satish Gopal

doi:10.1371/journal.pmed.1002351

Cancer trials in sub-Saharan Africa: Aligning research and care

PLoS Med. 2017 Jul 10;14(7):e1002351. doi: 10.1371/journal.pmed.1002351. eCollection 2017 Jul.

Author

Satish Gopal^{1

2

3

4

5

6}

Affiliations

¹ Malawi Cancer Consortium, Lilongwe, Malawi.
² UNC Project-Malawi, Lilongwe, Malawi.
³ Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
⁴ Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
⁵ Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
⁶ University of Malawi College of Medicine, Blantyre, Malawi.

Abstract

Satish Gopal discusses the challenges of deliverable cancer care and cancer trials in sub-Saharan Africa as well as a potential framework for overcoming these challenges.

MeSH terms

Africa South of the Sahara
Antineoplastic Agents / therapeutic use*
Clinical Trials as Topic*
Humans
Neoplasms / drug therapy*

Substances

Antineoplastic Agents

Abstract

MeSH terms

Substances

Grants and funding